Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 4,851–4,875 of 7,816 matching trials · page 195 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Doll Therapy on Patients With Moderate and Severe Dementia NCT04120103 Doll therapy; Routine nursing care Runs in: Turkey (Türkiye) · 1 site |
NA other |
COMPLETED | 29 | Aksaray University Training and Research Hospital OTHER |
2021-08-12 |
|
A Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease NCT03117738 AstroStem; Placebo-Control Runs in: United States · 3 sites |
PHASE1|PHASE2 other |
COMPLETED | 21 | Nature Cell Co. Ltd. INDUSTRY |
2021-08-10 |
|
Trial to Reduce Antimicrobial Use In Nursing Home Residents With Alzheimer's Disease and Other Dementias NCT03244917 TRAIN-AD Runs in: United States · 1 site |
NA other |
COMPLETED | 430 | Hebrew SeniorLife OTHER |
2021-08-10 |
|
The Effect of Video Game Exercise on Dynamic Balance and Gait in Individuals With Huntington's Disease NCT01735981 Video game exercise using Dance Dance Revolution; hand-held video game Runs in: United States · 1 site |
NA other |
COMPLETED | 24 | Anne Kloos OTHER |
2021-08-09 |
|
Retinoic Acid Homeostasis in Neuropsychiatric Diseases NCT02439099 Runs in: Germany · 1 site |
NA other |
UNKNOWN | 200 | Charite University, Berlin, Germany OTHER |
2021-08-09 |
|
Evaluation of Lithium as a Glycogen-Synthase-Kinase-3 (GSK-3) Inhibitor in Mild Cognitive Impairment NCT02601859 Lithium Carbonate |
NA other |
COMPLETED | 11 | University of Dundee OTHER |
2021-08-09 |
|
SettleIN - Adjustment to Care in Dementia: An Intervention Feasibility Study v0.1 NCT02682472 SettleIN - Adjustment to care programme Runs in: United Kingdom · 1 site |
NA other |
UNKNOWN | 24 | University College, London OTHER |
2021-08-09 |
|
Cross-Cultural Use of Performance-Based Functional Assessment in Alzheimer's Disease NCT03081546 Runs in: United States · 1 site |
NA other |
COMPLETED | 41 | University of Colorado, Denver OTHER |
2021-08-09 |
|
A Single Ascending Dose Study to Investigate the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Intravenously Administered RO7126209 in Healthy Participants NCT04023994 RO7126209; Placebo Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 36 | Hoffmann-La Roche INDUSTRY |
2021-08-09 |
|
The Assessment of the Diagnosis and Prognosis of Patients With Alzheimer Disease or Parkinson Disease With Cognitive Impairment by Using Diffusion MRI NCT04434898 Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 212 | Chang Gung Memorial Hospital OTHER |
2021-08-06 |
|
A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease NCT03131453 CNP520 50mg; CNP520 15mg; Matching placebo Runs in: Argentina; Australia; Belgium; Canada; Chile; China; Finl... · 194 sites |
PHASE2|PHASE3 other |
TERMINATED | 1,145 | Novartis Pharmaceuticals INDUSTRY |
2021-08-05 |
|
Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults NCT04313127 Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Runs in: China · 1 site |
PHASE1 other |
COMPLETED | 108 | CanSino Biologics Inc. INDUSTRY |
2021-08-04 |
|
The Effectiveness of Acupuncture for Delirium in Critically Ill Patients NCT04312893 Acupuncture (Press Tack Needle); press tack placebo Runs in: Taiwan · 1 site |
NA other |
UNKNOWN | 80 | China Medical University Hospital OTHER |
2021-08-03 |
|
This is a Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease NCT01676935 ABT-126 Runs in: Poland; Russia; South Africa; Ukraine; United Kingdom; Un... · 29 sites |
PHASE2 other |
TERMINATED | 349 | AbbVie (prior sponsor, Abbott) INDUSTRY |
2021-08-02 |
|
Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease NCT01690195 ABT-126 Runs in: Canada; France; Germany; Greece; South Africa; United Kin... · 39 sites |
PHASE2 other |
TERMINATED | 343 | AbbVie (prior sponsor, Abbott) INDUSTRY |
2021-08-02 |
|
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext NCT01741194 AC-1204; Placebo Runs in: United States · 82 sites |
PHASE2|PHASE3 other |
COMPLETED | 418 | Cerecin INDUSTRY |
2021-08-02 |
|
Auburn University Research on Olive Oil for Alzheimer's Disease (AU-ROOAD) NCT03824197 EVOO; OO Runs in: United States · 1 site |
NA other |
COMPLETED | 25 | Auburn University OTHER |
2021-08-02 |
|
Sunphenon EGCg (Epigallocatechin-Gallate) in the Early Stage of Alzheimer´s Disease NCT00951834 Epigallocatechin-Gallate; Placebo Runs in: Germany · 3 sites |
PHASE2|PHASE3 other |
COMPLETED | 21 | Charite University, Berlin, Germany OTHER |
2021-07-29 |
|
Epileptiform Activity During REM Sleep in Alzheimer's Disease NCT03923569 Overnight polysomnography; blood sample; high-resolution MRI scan; ... Runs in: France · 1 site |
NA other |
UNKNOWN | 62 | University Hospital, Toulouse OTHER |
2021-07-28 |
|
COVID-19 Infections and Mortality in Long-term Care Facilities During the First Wave NCT04782427 COVID-19 infection Runs in: Canada · 1 site |
NA other |
COMPLETED | 1,197 | Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal OTHER_GOV |
2021-07-28 |
|
Multidisciplinary Intervention for Mild Cognitive Impairment NCT02943187 Cognitive training; Nutrition Runs in: United States · 1 site |
NA other |
UNKNOWN | 5 | Gibson Institute of Cognitive Research INDUSTRY |
2021-07-27 |
|
Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease NCT03806478 APH-1105; Placebo |
PHASE2 other |
UNKNOWN | 60 | Aphios INDUSTRY |
2021-07-27 |
|
Care at 360º: A Long-term Individual Cognitive Stimulation Program NCT04417751 Cognitive Stimulation Runs in: Portugal · 1 site |
NA other |
COMPLETED | 59 | CEDIARA - Assoc. Solidariedade Social de Ribeira de Fráguas OTHER |
2021-07-27 |
|
Study of Neurobiological Predictors of Response to Non-invasive Neurostimulation and Genetic Susceptibility to Dementia in Patients With Amnestic Mild Cognitive Impairment NCT04943003 Transcranial Direct Current Stimulation (tDCS) Runs in: Brazil · 1 site |
NA other |
UNKNOWN | 50 | Suellen Marinho Andrade OTHER |
2021-07-27 |
|
The Protective Effect of Omega-3 Fatty Acid on Cognitive Function Among Patients With Mild Dementia NCT04972643 EPA; DHA; Placebo Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 163 | Taichung Veterans General Hospital OTHER |
2021-07-26 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial